Ornithine decarboxylase inhibition or NMDA receptor antagonism reduce cortical polyamine efflux associated with dialysis probe implantation.
Dialysis probe implantation in the rat parietal cortex results in delayed, prolonged and biphasic increases in the efflux of putrescine and spermidine with primary and secondary efflux peaks 6-8 h and 20-24 h after implantation. Putrescine and spermidine efflux remain elevated for at least 30 h after implantation. The primary efflux peak is attenuated by the continual infusion via the dialysis probe of either the ornithine decarboxylase inhibitor difluoromethylornithine or by the NMDA antagonist 2-APV. The secondary peak is resistant to either of these treatments. These changes in polyamine outflow are likely related to the traumatic brain damage associated with dialysis probe implantation which may be a useful model to study the effects of local brain trauma.
Fage
D
D
Synthelabo Recherche (LERS), Biology Department, Bagneux, France.
Carboni
S
S
Voltz
C
C
Scatton
B
B
Carter
C
C
D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D000818:Animals; D015317:Biogenic Polyamines / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D003956:Dialysis; D000518:Eflornithine / Q000494:pharmacology; D008297:Male; D065108:Ornithine Decarboxylase Inhibitors; D011700:Putrescine / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D013095:Spermidine / Q000378:metabolism
D015317:Biogenic Polyamines; D065108:Ornithine Decarboxylase Inhibitors; D016194:Receptors, N-Methyl-D-Aspartate; D015763:2-Amino-5-phosphonovalerate; D013095:Spermidine; D011700:Putrescine; D000518:Eflornithine